BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7437912)

  • 1. Aging process affects a single class of dopamine receptors.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M; Battaini F; Spano PF; Trabucchi M
    Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
    Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P; Rupniak NM; Marsden CD
    Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine metabolism, spiperone binding and adenylate cyclase activity in the adult rat hippocampus after ingrowth of dopaminergic neurones from embryonic implants.
    Bischoff S; Scatton B; Korf J
    Brain Res; 1979 Dec; 179(1):77-84. PubMed ID: 509234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC; Onali P
    Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal mechanisms regulating ethanol effects on the dopaminergic system.
    Barbaccia ML; Bosio A; Lucchi L; Spano PF; Trabucchi M
    Life Sci; 1982 Jun; 30(25):2163-70. PubMed ID: 7202095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
    Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
    Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of pergolide with central dopaminergic receptors.
    Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.